← Back to Search

Systems consultation for Opioid Use Disorder

N/A
Waitlist Available
Led By Andrew Quanbeck, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 months
Awards & highlights

Study Summary

This trial is testing different combinations of strategies to help clinics and doctors adopt clinical guidelines for opioid prescribing, in order to find the best way to improve prescribing practices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average morphine milligram equivalent (MME) of chronic opioid prescriptions of clinics
Average morphine milligram equivalent of chronic opioid prescriptions of prescribers
Secondary outcome measures
Average hours of intervention received per clinic
Average hours of intervention received per prescriber
Average morphine milligram equivalent of patients who are co-prescribed opioids and benzodiazepines
+17 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: Academic detailing+practice facilitation+physician peer consulExperimental Treatment1 Intervention
Clinicians will receive academic detailing at month 0 and practice facilitation at month 3. At month 6, clinics will be randomized to receive physician peer consulting. Clinicians of the clinics will meet up to 4 times, quarterly, with the physician peer consultant.
Group II: Academic detailing+practice facilitationExperimental Treatment1 Intervention
Clinicians of this group will attend an educational meeting and receive a monthly audit and feedback report for 18 months. At month 3, clinics will be randomized to receive practice facilitation. Clinics will be asked to follow-up with the facilitators via phone or video chat monthly for months 4-6, then quarterly for months 7-18.
Group III: Academic detailing+physician peer consultingExperimental Treatment1 Intervention
Clinicians of this group will attend an educational meeting and will receive a monthly audit and feedback report for 18 months. At month 6, clinicians of the clinics will meet up to 4 times, quarterly, with the physician peer consultant.
Group IV: Academic detailing onlyExperimental Treatment1 Intervention
Clinicians will attend an educational meeting and receive audit and feedback reports for 18 months.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,581 Total Patients Enrolled
University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,396 Total Patients Enrolled
Andrew Quanbeck, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
856 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Promoting Clinical Guidelines for Opioid Prescribing
2020. "Promoting Clinical Guidelines for Opioid Prescribing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04044521.
~29 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top